radiotherapy of gastric lymphoma
DESCRIPTION
TRANSCRIPT
![Page 1: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/1.jpg)
Management of Gastric Lymphoma
withRadiation Therapy
Dr. V . Lokesh M.D.Associate Professor
Dept of Radiation Oncology, KMIO, Bangalore 29
![Page 2: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/2.jpg)
GASTRIC LYMPHOMA• Primary gastric lymphoma is rare however, the incidence of this
malignancy is increasing.
• Any portion of GI tract can be involved with systemic NHL
• Gastric Lymphoma is the most common extranodal site (50-60%)
• Arise from B cells of mucosa-associated lymphoid tissue (MALT)
• <15%of gastric malignancies and 2%of all lymphomas
![Page 3: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/3.jpg)
GASTRIC LYMPHOMA
• MALT lymphomas arise in the setting of mucosal lymphoid activation due to H. pylori infection
• HP causes activation of T and B cells leading to B cell hyperplasia and the emergence of a monoclonal B cell population
• Primary GI lymphomas are amenable to treatment
![Page 4: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/4.jpg)
Major histological subtypes of gastric lymphoma
Low- grade GL:
• Low- grade B cell lymphoma of MALT
(approximately 45% of cases).
Histologically aggressive GL:
• Diffuse large B- cell lymphoma
(approximately 45% of cases).
![Page 5: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/5.jpg)
Stage
IE Lymphoma limited to the stomach
IIE1
Involvement of stomach and contiguous lymph nodes
(Peri-gastric area / Level L1 – L2)
IIE2 Involvement of stomach and noncontiguous
subdiaphragmatic lymph nodes(L3 downwards or in mesentry)
IIIInvolvement of stomach and lymph nodes on
both sides of diaphragm
Indications for Radiation Therapy (Ann Arbor, modified by Musshoff)
![Page 6: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/6.jpg)
MALT – RT indications
• H pylori +ve (endoscopy / CT)
– response : 35 – 100%
– Eradicated in 85 - 90%
– 30-50% will show persistent or progression even after eradication
– 15% relapse within 3years of CR
• H pylori –veContn ..
![Page 7: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/7.jpg)
• H pylori +ve :– show markedly decreased response when– node +ve– penetration beyond mucosa– distal part of stomach– with high grade component – Chromosomal translocation t(11;18)(q21;q21)
~25% superficial • 67% non responders• t(11;18) –ve have a higher risk of transformation to
diffuse B-cell – incomplete regression – closely monitored – therapeutic alternatives
![Page 8: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/8.jpg)
RT - Treatment Intent
• Radical - localized NHL (treated with curative intent).
• Palliative - used when condition of the patient, the extent and location of disease, or the nature of the disease, a radical treatment offers no opportunity for cure.
![Page 9: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/9.jpg)
• RT alone : Stage I E , MALT• radiotherapy is used as an adjuvant to surgery,
chemotherapy or both• CT RT : aggressive lymphomas all stages• Post OP RT / Bx: as adjuvant
– potentially curative resections. – Incomplete resection– Margin + ve– Multifocal disease– Penetration of bowel wall stage I : microscopic (R1) or macroscopic (R2) stage II disease: (R0), R1 or R2 resection
Radiation Therapy Sequencing
![Page 10: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/10.jpg)
RT TechniquesAim of RT : homogeneous distribution of irradiation dose
within the target area.
Current irradiation techniques :Use Simulators, Computer Planning System to custom-designed fields that conform to the individual patient's anatomy and tumor location
Techniques • parallel opposed fields AP:PA • three or four-field
use of beam-modifying devices - shields - Compensators- Patient immobilizing devices
![Page 11: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/11.jpg)
Radiation Therapy - treatment plan takes into consideration • all staging data• normal anatomical structures in the vicinity• common routes of lymphatic spread• appreciation of the radiation therapy tolerance of normal
organs and tissues.
common terms used • involved field• extended field• total lymphoid irradiation (TLI)• Whole-Abdomen Treatment : mesenteric lymph nodes –
involved
![Page 12: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/12.jpg)
RT Planning & DoseDefinition of • the treatment volume
– Stomach – +/- Duodenum or GO Junction – + Perigasrtic & Regional Lymphnode
• critical organs and dose-limiting structures.
The doses used to treat NHL are usually lower than those required to control solid tumors, allowing irradiation of larger volumes of tissue with a lower risk of serious complications.
RT Doses of 30 to 45 Gy
– Large Volumes: 125-150cGy/Fraction, 5Fx/week– Small volume : 180 cGy/Fx, 5Fx/week
![Page 13: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/13.jpg)
interfractional gastric movement during radiation therapy.
Tumor position and location - clips endoscopically placed
directions : Target Motion range
lateral : 5 and 35 mm (mean 24 mm) cephalocaudal:0-15 mm (8 mm).
![Page 14: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/14.jpg)
RT Machines• Telecobalt
• Linear Accelerator
![Page 15: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/15.jpg)
Recent Advances
• 3 DCRT – 3D Conformal
• IMRT - Intensity Modulated
• IGRT
• Tomotherapy
• Cyber Knife
![Page 16: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/16.jpg)
Tomotherapy
linacMLC
![Page 17: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/17.jpg)
CyberKnife
![Page 18: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/18.jpg)
Simulation X- Ray
![Page 19: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/19.jpg)
![Page 20: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/20.jpg)
![Page 21: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/21.jpg)
![Page 22: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/22.jpg)
![Page 23: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/23.jpg)
![Page 24: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/24.jpg)
![Page 25: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/25.jpg)
![Page 26: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/26.jpg)
![Page 27: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/27.jpg)
Radiation treatment planning techniques for lymphoma of the stomach.
type I: patients (no overlap between PTV and kidneys)- there was essentially no benefit from using 3DCRT over AP/PA.
type II : PTVs in close proximity to the kidneys) type III: with high degree of overlap – the 4-field 3DCRT plans were superior, reducing the kidney V(15 Gy)
by approximately 90% for type II and 50% for type III patients. – For type III, the use of a 3DCRT plan rather than an AP/PA plan
decreased the V(15 Gy) by approximately 65% for the right kidney and 45% for the left kidney.
– In the selected cases, IMRT led to a further decrease in left kidney dose as well as in mean liver dose.
– The addition of IMRT led to further incremental improvements in the left kidney and liver dose in selected patients.
![Page 28: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/28.jpg)
RESULTS
![Page 29: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/29.jpg)
Gastric Lymphoma Localized treated with radiation therapy
PRE RT
End of RTF/U – at 1 yr
![Page 30: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/30.jpg)
MALT (MSKCC)
• n = 51 (h.pylori –ve / persistant after antibiotic therapy)
• Stage I – 39, II – 10, IV – 2
• RT : stomach + perigastric lymph nodes
: 30Gy in 4 weeks
• CR – 96% (49/51)
• 4yrs f/u : • freedom from treatment failure – 89%, • OS – 83%• cause specific survival – 100%.
![Page 31: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/31.jpg)
Adjuvant therapy:
• Resectability rate : 60-80%– Curative resection – 50-87% (5yrs survival)– Non –resectable – 6-40%
• Stage IE : RT alone = S + RT ~ 85% (burgers et al)
![Page 32: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/32.jpg)
RT & CT
• Maro et al
• n =34 (Stage IE & II E )
• 5 – 15 yrs OS - 68%
![Page 33: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/33.jpg)
• Koch, P. et al S• n =747.• 393 with localized PGL• Treated with radiotherapy and/or chemotherapy only
or additional surgery • The survival rate at 42 months for patients treated with
surgery was 86% compared with 91.0% for patients without surgery.
![Page 34: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/34.jpg)
![Page 35: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/35.jpg)
acute radiation side effects
• mild nausea (RTOG Grade 1) -100%
• appetite loss -Grade 1 < 5%.
• no severe late adverse events.
• left kidney atrophy of approximately 10%, but no renal dysfunction < 1%.
![Page 36: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/36.jpg)
Radiotherapy Results & Conclusion
survival rates
• stage IE and IIE : 80%-89% .
• early stages of MALT lymphomas not responding to antibiotics: 93%
• post-operative RT (in high- and low-grade lymphomas) for any residual tumors in stages I and II : improve the disease free survival. Stage IE : RT alone = S + RT ~ 85% (burgers et al)
![Page 37: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/37.jpg)
• Combined chemotherapy - improves the
chance of stomach conservation ~100%.
• combined radiotherapy with either
resection or chemotherapy is not
significantly difference in both modalities
with a survival rate of 82%-88%.
• No risk of bleeding or perforation
• Equivalent outcome can be attained
without gastric resection
![Page 38: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/38.jpg)
![Page 39: Radiotherapy Of Gastric Lymphoma](https://reader033.vdocuments.mx/reader033/viewer/2022061114/5462bfbfb4af9f5d1c8b4963/html5/thumbnails/39.jpg)
Primary gastrointestinal lymphoma--disease spectrum and management : a 15-year review from north India.
Singh DP et al, Postgraduate Institute of Medical Education and Research, Chandigarh.,
• Seventy five • 1971 -1985 • Age: 3.5-69 years (mean 34) at presentation• Histologically,
– diffuse poorly-differentiated lymphocytic lymphoma (46.7%) and diffuse histiocytic type (30.7%).
• stage I - 27(36%) • stage II - 31 (40%) • stage III - 11 (14.7%) • stage IV - 6 (8%).
– Surgery:• primary resection - 66 • biopsies -9
– Treatment {mean follow-up was 3.9 years (range 1-14)}. • adjuvant radiation with or without chemotherapy - 48 • The 5-year actuarial survival was• stages I - 34%, II- 25% and higher-stage- 16% • The survival was significantly better (p < 0.01) for gastric location (44%) compared to
other sites (24%).